Live
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
CNBC · Center
Western biopharma companies are increasingly turning to China to source innovation, as pharma’s dreaded “patent cliff” draws closer.
Read the full story at the original publisher
CNBC →
-
Amelia Earhart mystery continues after search based on ‘satellite photo of plane’The Independent World Leans Left3 days ago
-
Republican candidate forced out of race after suspected drunk driving crash leaves car overturnedThe Independent World Leans Left3 days ago
-
Democrat who told Susan Collins to ‘shut up’ doubles down and refuses to apologizeThe Independent World Leans Left3 days ago
Leave a Reply